Xuezhong Yu to Humans
This is a "connection" page, showing publications Xuezhong Yu has written about Humans.
Connection Strength
0.369
-
The druggable transcription factor Fli-1 regulates T cell immunity and tolerance in graft-versus-host disease. J Clin Invest. 2022 11 01; 132(21).
Score: 0.032
-
S1P/S1PR1 signaling differentially regulates the allogeneic response of CD4 and CD8 T cells by modulating mitochondrial fission. Cell Mol Immunol. 2022 Nov; 19(11):1235-1250.
Score: 0.031
-
Ceramide synthase 6 impacts T-cell allogeneic response and graft-versus-host disease through regulating N-RAS/ERK pathway. Leukemia. 2022 07; 36(7):1907-1915.
Score: 0.031
-
Interleukin-23 receptor signaling by interleukin-39 potentiates T cell pathogenicity in acute graft-versus-host disease. Am J Transplant. 2021 11; 21(11):3538-3549.
Score: 0.029
-
Lysosomal Acid Lipase Is Required for Donor T Cells to Induce Graft-versus-Host Disease. Cell Rep. 2020 10 27; 33(4):108316.
Score: 0.028
-
Targeting the Complement Alternative Pathway Permits Graft Versus Leukemia Activity while Preventing Graft Versus Host Disease. Clin Cancer Res. 2020 07 01; 26(13):3481-3490.
Score: 0.026
-
The IL-12 Cytokine and Receptor Family in Graft-vs.-Host Disease. Front Immunol. 2019; 10:988.
Score: 0.025
-
Modelling CAR-T therapy in humanized mice. EBioMedicine. 2019 Feb; 40:25-26.
Score: 0.024
-
T-Cell Metabolism in Hematopoietic Cell Transplantation. Front Immunol. 2018; 9:176.
Score: 0.023
-
IL-17A ? Th17 in GvHD. Cell Mol Immunol. 2018 03; 15(3):282-283.
Score: 0.021
-
Inhibition of BTK and ITK with Ibrutinib Is Effective in the Prevention of Chronic Graft-versus-Host Disease in Mice. PLoS One. 2015; 10(9):e0137641.
Score: 0.019
-
Essential Role of Interleukin-12/23p40 in the Development of Graft-versus-Host Disease in Mice. Biol Blood Marrow Transplant. 2015 Jul; 21(7):1195-204.
Score: 0.019
-
Chronic cannabis smoking-enriched oral pathobiont drives behavioral changes, macrophage infiltration, and increases ?-amyloid protein production in the brain. EBioMedicine. 2021 Dec; 74:103701.
Score: 0.007
-
Nuclear PFKP promotes CXCR4-dependent infiltration by T cell acute lymphoblastic leukemia. J Clin Invest. 2021 08 16; 131(16).
Score: 0.007
-
Aging-dependent mitochondrial dysfunction mediated by ceramide signaling inhibits antitumor T?cell response. Cell Rep. 2021 05 04; 35(5):109076.
Score: 0.007
-
RNA binding protein PCBP1 is an intracellular immune checkpoint for shaping T cell responses in cancer immunity. Sci Adv. 2020 05; 6(22):eaaz3865.
Score: 0.007
-
Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell Response. Clin Cancer Res. 2019 02 01; 25(3):1036-1049.
Score: 0.006
-
Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic. Cancer Immunol Immunother. 2016 Mar; 65(3):247-59.
Score: 0.005
-
A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma. Oncotarget. 2015 Dec 01; 6(38):41383-97.
Score: 0.005
-
NF-?B-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis. Nat Commun. 2015 Jul 03; 6:7652.
Score: 0.005
-
Soluble NKG2D ligand promotes MDSC expansion and skews macrophage to the alternatively activated phenotype. J Hematol Oncol. 2015 02 20; 8:13.
Score: 0.005
-
Reducing CD73 expression by IL1?-Programmed Th17 cells improves immunotherapeutic control of tumors. Cancer Res. 2014 Nov 01; 74(21):6048-59.
Score: 0.004
-
Tolerance induction between two different strains of parental mice prevents graft-versus-host disease in haploidentical hematopoietic stem cell transplantation to F1 mice. Biochem Biophys Res Commun. 2014 Apr 18; 446(4):1035-41.
Score: 0.004